Tech Company Financing Transactions
Noxilizer Funding Round
Private investors participated in a $2.3 million Series C capital raise for Noxilizer. The round was announced on 2/10/2009.
Transaction Overview
Company Name
Announced On
2/10/2009
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1334 Ashton Rd. E
Hanover, MD 21076
USA
Hanover, MD 21076
USA
Phone
Website
Email Address
Overview
Noxilizer, Inc. is developing proprietary, next-generation sterilization technology that is fast, safe and benign to many materials and bioactive compounds. The Noxilizer technology has the potential to provide improved safety and enable the commercialization of new, advanced medical implants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Bruder
General Manager
Ryuichi Iwasaki
VP - Bus. Development
Maura Kahn
VP - R & D
David Opie
VP - Regulatory Affairs
Mary Dadone
Browse more venture capital transactions:
Prev: 2/10/2009: HX Diagnostics venture capital transaction
Next: 2/11/2009: Outbrain venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs